CCA patients showed significantly increased levels of MHC II, CD14, CD29, CD40, and HLA-ABC on EVs in TP both pre T and post T compared to HV (p < 0.05, Figure 5A). The gene discussed is CD14; the disease is cholangiocarcinoma.